(Q34205524)

31 July 2017

title

Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior (English)

1 reference

31 July 2017

0 references

Joseph C Blader

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Journal of Clinical Psychopharmacology

31 July 2017

published in

1 reference

31 July 2017

volume

26

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

419-425

1 reference

Symptom, family, and service predictors of children's psychiatric rehospitalization within one year of discharge

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Antidepressants and suicide: risk-benefit conundrums

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Psychotropic practice patterns for youth: a 10-year perspective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Methylphenidate does not modify the impact of response frequency or stimulus sequence on performance and event-related potentials of children with attention deficit hyperactivity disorder.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

The effects of conduct disorder and attention deficit in middle childhood on offending and scholastic ability at age 13.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2956076

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

28 October 2018

1 reference

12 December 2020

Safeguards for children taking antidepressants strengthened

1 reference

12 December 2020

Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings

1 reference

12 December 2020

Combined pharmacotherapy in children and adolescents in a residential treatment center

1 reference

12 December 2020

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

12 December 2020

Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention deficit hyperactivity disorder

1 reference

12 December 2020

Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice

1 reference

12 December 2020

Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings

1 reference

12 December 2020

10.1097/01.JCP.0000227356.31203.8A

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference